Lyka Labs Ltd share price logo

Lyka Labs Share Price (LYKALABS)

Check the latest share price of Lyka Labs, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹121.67

1.59%

as on 04:01PM, 30 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Lyka Labs Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹120.72
    Day's Price Range
    ₹123.96
  • 52 Week's Low

    52 Week's High

    ₹96.8
    52-Week Price Range
    ₹176.59
1 Month Return+ 10.27 %
3 Month Return+ 19.97 %
1 Year Return+ 12.4 %
3 Year Return+ 1.05 %
5 Year Return+ 658.07 %
Previous Close₹123.63
Open₹123.96
Volume53.53K
Upper Circuit₹148.35
Lower Circuit₹98.90

Lyka Labs Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹434.24 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

54.81

Return on capital employed (ROCE)

0

Industry PE ratio

56.12

Beta (LTM)

1.19

P/B Ratio

3.88

Dividend Yield

0

PEG Ratio

8.78

Quarterly Earnings Growth YOY

-197.13

EPS (TTM)

-0.79

Sector

Pharmaceuticals

Book Value

17.86

Technical Analysis

How to invest in Lyka Labs?

Investing in Lyka Labs is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Lyka Labs or LYKALABS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Lyka Labs or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Lyka Labs with just a few clicks!

Lyka Labs Stock's Interest Amongst Investors

-6%

Period Jun 01, 2025 to May 02, 2025. Change in 30 Days vs previous period

Search interest for Lyka Labs Ltd Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Lyka Labs Valuation

Track how the P/E of Lyka Labs has moved over time to understand valuation trends.

Lyka Labs in the last 5 years

  • Overview

  • Trends

Lowest (-164.66x)

September 10, 2018

Today (54.81x)

May 30, 2025

Industry (56.12x)

May 30, 2025

Highest (55.69x)

May 29, 2025

LowHigh

Today’s Price to Earnings Ratio: 54.81x

Lyka Labs Financials

Get the annual and quarterly financial summary of Lyka Labs, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

28 (0%)30 (8%)41 (37%)34 (18%)33 (1%)
Net Income

(in ₹ Cr)

-2 (0%)1 (169%)2 (46%)3 (29%)2 (25%)
Net Profit Margin-7.53% (0%)4.78% (163%)5.10% (7%)7.99% (57%)6.07% (24%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

213 (0%)209 (2%)179 (14%)186 (4%)
Total Liabilities

(in ₹ Cr)

208 (0%)163 (22%)101 (38%)85 (16%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-11 (0%)6 (150%)77 (1231%)7 (91%)3 (55%)

Lyka Labs Earnings and Dividends

View detailed summary of the earnings and dividend history of Lyka Labs.

  • Lyka Labs Ltd Earnings Results

    Lyka Labs Ltd’s net profit jumped 197.13% since last year same period to ₹2.03Cr in the Q4 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated -24.81% fall in its net profits since last 3-months.

    Read More about Earnings Results

Lyka Labs Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Lyka Labs.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
58.16%
0.00
Foreign Institutions
0.23%
0.00
Mutual Funds
0.01%
0.00
Retail Investors
40.94%
0.00
Others
0.66%
0.00

Lyka Labs vs Peers

Compare market cap, revenue, PE, and other key metrics of Lyka Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA434.24131.61%0.69NANA
NA177.3853.69%0.62NANA
NA19,930.0031.61%0.51NANA
NA45.3613.89%0.51NANA
NA1,054.8625.92%0.51NANA

Lyka Labs News & Key Events

Latest news and events at one place to help you take investing decisions in Lyka Labs.

  • Lyka Labs Patent Boosts Stock with 10% Surge - 08 Apr, 2025

    Lyka Labs Limited announced the grant of an Indian patent for Pregabalin Gel 8%, a topical solution for diabetic neuropathic pain, valid until 2043. Following this news, the stock surged by 10%, reflecting investor confidence in this innovative product's potential in pain management.

Insights on Lyka Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.15% to 0.23% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 58.10% to 58.16% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LYKALABS stock has moved up by 3.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 124.2% return, outperforming this stock by 123.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 53.5% return, outperforming this stock by 41.1%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 41.08% to 40.94% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 41.18 Cr → 34.25 Cr (in ₹), with an average decrease of 8.5% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 2.7 Cr → 2.03 Cr (in ₹), with an average decrease of 24.8% per quarter

About Lyka Labs

Lyka Labs, a bulk drug company, has been in the business of offering lifesaving antibiotics and treating minor infections for over three decades. Over the years, the company has also diversified into marketing medical and diagnostic machinery and equipment, ayurvedic and animal health care products, tropical steroids, anticancer products, cardiovascular drugs, and anti-inflammatory products. In the year 1991 they received a Certificate of Merit for their impressive export performance and an award from CHEMEXCIL. Two years later, their Administrative Office and Plant at Tarapur was awarded the ISO 9002 certification for its quality management system. As part of its diversification, the company had also invested in Relic Finance and acquired 26.70% of the company's paid-up equity capital through a public offer. They also launched India's first Glutathione Injection formulation during 2012-13 to become one of India's leading healthcare and pharmaceutical companies.

Revenue: ₹33.43Cr as on March 2025 (Q4 FY25)
Net Profit: ₹2.03Cr as on March 2025 (Q4 FY25)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
OrganisationLyka Labs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOKUNAL NARENDRA GANDHI
E-voting on sharesClick here to vote

FAQs

What is Lyka Labs share price today?

Lyka Labs share price today stands at ₹121.67, Open: ₹123.96, Previous Close: ₹123.63, High: ₹123.96, Low: ₹120.72, 52 Week High: ₹176.59, 52 Week Low: ₹96.8.

What is today's traded volume of Lyka Labs?

Today's traded volume of Lyka Labs is 53.53K. Which means that 53.53K shares of Lyka Labs were bought and sold on the stock market during today's trading session.

What is Lyka Labs's market cap today?

Today's market capitalisation of Lyka Labs is ₹434.24 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Lyka Labs?

Lyka Labs’s 52 week high is ₹176.59 and 52 week low is ₹96.8. The current share price of Lyka Labs is ₹121.67, which is -31.10% down from its 52 week high and 25.69% up from its 52 week low.